PC
CASC

PointState Capital’s Cascadian Therapeutics, Inc. CASC Stock Holding History

PointState Capital’s Portfolio CASC Stock Details CASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-83,333
Closed -$1.03M – 180
2013
Q3 		$1.03M Buy
+83,333
New +$1.03M 0.02% 118